当前位置: X-MOL首页全球导师 国内导师 › 李亚平

研究领域

1. 基于纳米技术的药物靶向递释系统 2. 核酸药物非病毒载体及其导入系统 3. 药物新剂型与新制剂的研究开发

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Xinyu He, Xiaoyue Bao, Haiqiang Cao, Zhiwen Zhang*, Qi Yin, Wangwen Gu, Lingli Chen, Haijun Yu, Yaping Li*. Tumor-penetrating Nanotherapeutics Loading a Near-infrared Probe Inhibit Growth and Metastasis of Breast Cancer. Adv Funct Mater (2015, Accepted). Haijun Yu*, Zhirui Cui, Pengcheng Yu, Chengyue Guo, Bing Feng, Tongying Jiang, Siling Wang, Qi Yin, Dafang Zhong, Xiangliang Yang, Zhiwen Zhang, Yaping Li*. pH and near-Infrared light-responsive micelles with hyperthermia-triggered tumor penetration and cytoplasm drug release reverse doxorubicin resistance in breast cancer. Adv Funct Mater (http://dx.doi.org/10.1002/adfm.201404484) Meiying Wu, Qingshuo Meng, Yu Chen*, Yanyan Du, Lingxia Zhang, Yaping Li*, Linlin Zhang, Jianlin Shi*. Large pore-sized ultrasmall mesoporous organosilica nanoparticles: micelle/precursor co-templating assembly and nuclear-targeted gene delivery. Adv Mater 27(2015)215-22. Shan Tang, Qi Yin*, Jinghan Su, Huiping Sun, Qingshuo Meng, Yi Chen, Lingli Chen, Yongzhuo Huang, Wangwen Gu, Minghua Xu, Haijun Yu, Zhiwen Zhang, Yaping Li*. Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel. Biomaterials 48(2015)1-15 Yu Chen, Qingshuo Meng, Meiying Wu, Shige Wang, Pengfei Xu, Hangrong Chen, Yaping Li.* Lingxia Zhang, Lianzhou Wang,* Jianlin Shi*. Hollow mesoporous rganosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine. J Am Chem Soc 136(2014) 16326-34. Yu Chen, Pengfei Xu, Meiying Wu, Qingshuo Meng, Hangrong Chen,* Zhu Shu, Jin Wang, Lingxia Zhang, Yaping Li* and Jianlin Shi*. Colloidal RBCs-shaped, hydrophilic and hollow mesoporous carbon nanocapsules for highly efficient biomedical engineering. Adv Mater 26(2014)4294-301 Shan Tang, Qi Yin, Zhiwen Zhang, Wangwen Gu, Lingli Chen, Haijun Yu, Yongzhuo Huang, Xianzhi Chen, Minghua Xu, Yaping Li*. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer. Biomaterials 35(2014):6047-59 Zhiwen Zhang, Baohua Niu, Jian Chen, Xinyu He, Xiaoyue Bao, Jianhua Zhu, Haijun Yu, Yaping Li*. The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer. Biomaterials 35(2014)4565-72 Yu Chen, Pengfei Xu, Hangrong Chen, Yongsheng Li, Wenbo Bu, Zhu Shu, Yaping Li*, Jiamin Zhang, Lingxia Zhang, Limin Pan, Xiangzhi Cui, Zile Hua, Jin Wang, Linlin Zhang and Jianlin Shi*. Colloidal HPMO NPs:silica-etching chemistry tailoring, topological transformation and nano-biomedical applications. Adv Mater 25(2013):3100-5 Qi Yin, Jianan Shen, Zhiwen Zhang, Haijun Yu, Yaping Li*. Reversal of multidrug resistant by stimuli-responsive drug delivery systems for therapy of tumor. Adv Drug Deliv Rev 65(2013):1699-1715 Xiaopin Duan, Jisheng Xiao, Qi Yin, Zhiwen Zhang, Haijun Yu, Shirui Mao, Yaping Li*. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7(2013):5858-69 Zhiwen Zhang, Li Ma, Shijun Jiang, Zeying Liu, Jian Huang, Lingli Chen, Yaping Li*. A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor. J Control Release 166(2013):30-7 Jisheng Xiao, Xiaopin Duan, Qi Yin,Zhiwen Zhang, Haijun Yu, Yaping Li*. Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer. Biomaterials 34(2013):9648-56 Jisheng Xiao, Xiaopin Duan, Qi Yin, Zehong Miao*, Haijun Yu, Chunying Chen, Zhiwen Zhang*, Jun Wang, Yaping Li*. The inhibition of metastasis and growth of breast cancer by blocking the NF-κB signaling pathway using bioreducible PEI-based/p65 shRNA complex nanoparticles. Biomaterials 34(2013):5381-90 Jianan Shen, Huiping Sun, Pengfei Xu, Qi Yin, Zhiwen Zhang, Siling Wang, Haijun Yu, Yaping Li*. Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles. Biomaterials 34(2013):1581-90 Ge Zhang, Baosheng Guo, Heng Wu, Tao Tang, Bao-Ting Zhang, Lizhen Zheng, Yixin He, Zhijun Yang, Xiaohua Pan, Heelum Chow, Kinwah To, Yaping Li, Dahu Li, Xinluan Wang, Yixiang Wang, Kwongman Lee, Zhibo Hou, Nan Dong, Gang Li, Kwoksui Leung, Leungkim Hung, Fuchu He, Lingqiang Zhang & Ling Qin. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med 18(2012):307-14 Yu Chen, Yu Gao,Hangrong Chen,Deping Zeng, Yaping Li*, Yuanyi Zheng,Faqi Li,Xiufeng Ji,Xia Wang,Feng Chen,Qianjun He,Linlin Zhang,Jianlin Shi*. Engineering inorganic nanoemulsions/nanoliposomes by fluoride-Silica chemistry for efficient delivery/co-delivery of hydrophobic agents. Adv Funct Mater 8(2012):1586–97 Pengcheng Zhang, Luojuan Hu, Qi Yin, Linyin Feng, Yaping Li*. Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. J Control Release 159(2012):429-34 Qi Yin, Jianan Shen, Lingli Chen, Zhiwen Zhang, Wangwen Gu, Yaping Li*. Overcoming multidrug resistance by co-delivery of mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters). Biomaterials 33(2012):6495-506 Yu Gao, Yu Chen,Xiufeng Ji, Xinyu He,Qi Yin, Zhiwen Zhang, Jianlin Shi and Yaping Li*. Controlled intracellular release of doxorubicin in multidrug resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano 5(2011):9788-98

推荐链接
down
wechat
bug